AAPL355.63+7.12 (+2.04%) ▲|ABBV294.98+1.09 (+0.37%) ▲|ABT109.29-1.17 (-1.06%) ▼|ACN253.66-4.85 (-1.88%) ▼|ADBE237.60+0.90 (+0.38%) ▲|AMAT395.08+22.55 (+6.05%) ▲|AMD552.90+37.69 (+7.32%) ▲|AMGN468.11+2.88 (+0.62%) ▲|AMT190.24-0.13 (-0.07%) ▼|AMZN266.17-4.70 (-1.74%) ▼|AVGO345.22+13.24 (+3.99%) ▲|AXP323.11-0.35 (-0.11%) ▼|BA174.54+1.16 (+0.67%) ▲|BAC50.67-0.01 (-0.02%) ▼|BKNG160.21+0.95 (+0.60%) ▲|BLK1,226.31+4.16 (+0.34%) ▲|BMY62.91+0.11 (+0.18%) ▲|BNY152.69+1.55 (+1.03%) ▲|BRK-B588.24+4.90 (+0.84%) ▲|C124.21+1.94 (+1.59%) ▲|CAT601.61+17.04 (+2.92%) ▲|CL98.00-0.09 (-0.09%) ▼|CMCSA25.02+0.27 (+1.09%) ▲|COF197.11+1.27 (+0.65%) ▲|COP137.86+2.27 (+1.67%) ▲|COST1,087.61+21.47 (+2.01%) ▲|CRM218.01+4.53 (+2.12%) ▲|CSCO100.76+2.61 (+2.66%) ▲|CVS89.52+0.51 (+0.57%) ▲|CVX213.28+2.06 (+0.98%) ▲|DE691.75+4.11 (+0.60%) ▲|DHR235.31-0.80 (-0.34%) ▼|DIS119.65+0.44 (+0.37%) ▲|DUK128.77-0.17 (-0.13%) ▼|EMR167.06-0.48 (-0.29%) ▼|FDX322.63+3.15 (+0.99%) ▲|GD367.22-0.22 (-0.06%) ▼|GE342.75+4.84 (+1.43%) ▲|GEV808.24+11.20 (+1.41%) ▲|GILD169.73-1.14 (-0.67%) ▼|GM88.90+0.21 (+0.24%) ▲|GOOG290.63+5.71 (+2.00%) ▲|GOOGL293.45+6.07 (+2.11%) ▲|GS926.81+16.62 (+1.83%) ▲|HD351.31+0.31 (+0.09%) ▲|HON227.64-0.58 (-0.25%) ▼|IBM248.22+3.69 (+1.51%) ▲|INTC62.50+4.37 (+7.52%) ▲|INTU342.64+2.20 (+0.65%) ▲|ISRG449.53-0.51 (-0.11%) ▼|JNJ280.41-0.37 (-0.13%) ▼|JPM343.39+1.32 (+0.39%) ▲|KO97.57+0.66 (+0.68%) ▲|LIN526.55+4.77 (+0.91%) ▲|LLY1,437.29+5.00 (+0.35%) ▲|LMT610.05+6.93 (+1.15%) ▲|LOW231.60-0.27 (-0.12%) ▼|LRCX235.88+13.49 (+6.07%) ▲|MA660.73+1.89 (+0.29%) ▲|MCD274.80-7.37 (-2.61%) ▼|MDLZ66.70+0.16 (+0.24%) ▲|MDT101.61+0.02 (+0.02%) ▲|META628.77-12.62 (-1.97%) ▼|MMM188.88-0.49 (-0.26%) ▼|MO77.39+1.05 (+1.38%) ▲|MRK147.18-0.87 (-0.59%) ▼|MS190.61+3.05 (+1.63%) ▲|MSFT521.13-12.04 (-2.26%) ▼|MU811.30+86.19 (+11.89%) ▲|NEE85.99-0.28 (-0.32%) ▼|NFLX64.54+1.28 (+2.02%) ▲|NKE38.32-0.35 (-0.91%) ▼|NOW102.76+3.15 (+3.16%) ▲|NVDA173.73+4.93 (+2.92%) ▲|ORCL128.38+10.40 (+8.82%) ▲|PEP143.94+0.33 (+0.23%) ▲|PFE29.45+0.09 (+0.31%) ▲|PG167.67-0.99 (-0.59%) ▼|PLTR172.40+3.58 (+2.12%) ▲|PM196.35+2.10 (+1.08%) ▲|QCOM176.57+3.04 (+1.75%) ▲|RTX201.29+1.02 (+0.51%) ▲|SBUX109.89-0.06 (-0.05%) ▼|SCHW92.78-0.25 (-0.27%) ▼|SO93.84+0.19 (+0.20%) ▲|SPG234.75+0.27 (+0.12%) ▲|T22.26+0.32 (+1.46%) ▲|TMO717.71-0.49 (-0.07%) ▼|TMUS172.16+3.08 (+1.82%) ▲|TSLA390.84+11.06 (+2.91%) ▲|TXN309.81+9.29 (+3.09%) ▲|UBER70.68+0.63 (+0.90%) ▲|UNH402.94-2.18 (-0.54%) ▼|UNP302.11+1.49 (+0.50%) ▲|UPS112.45+1.40 (+1.26%) ▲|USB60.70-0.05 (-0.08%) ▼|V425.55+2.55 (+0.60%) ▲|VZ46.60+0.29 (+0.63%) ▲|WFC85.80+0.04 (+0.05%) ▲|WMT125.67+0.12 (+0.10%) ▲|XOM166.71+2.24 (+1.36%) ▲|AAPL355.63+7.12 (+2.04%) ▲|ABBV294.98+1.09 (+0.37%) ▲|ABT109.29-1.17 (-1.06%) ▼|ACN253.66-4.85 (-1.88%) ▼|ADBE237.60+0.90 (+0.38%) ▲|AMAT395.08+22.55 (+6.05%) ▲|AMD552.90+37.69 (+7.32%) ▲|AMGN468.11+2.88 (+0.62%) ▲|AMT190.24-0.13 (-0.07%) ▼|AMZN266.17-4.70 (-1.74%) ▼|AVGO345.22+13.24 (+3.99%) ▲|AXP323.11-0.35 (-0.11%) ▼|BA174.54+1.16 (+0.67%) ▲|BAC50.67-0.01 (-0.02%) ▼|BKNG160.21+0.95 (+0.60%) ▲|BLK1,226.31+4.16 (+0.34%) ▲|BMY62.91+0.11 (+0.18%) ▲|BNY152.69+1.55 (+1.03%) ▲|BRK-B588.24+4.90 (+0.84%) ▲|C124.21+1.94 (+1.59%) ▲|CAT601.61+17.04 (+2.92%) ▲|CL98.00-0.09 (-0.09%) ▼|CMCSA25.02+0.27 (+1.09%) ▲|COF197.11+1.27 (+0.65%) ▲|COP137.86+2.27 (+1.67%) ▲|COST1,087.61+21.47 (+2.01%) ▲|CRM218.01+4.53 (+2.12%) ▲|CSCO100.76+2.61 (+2.66%) ▲|CVS89.52+0.51 (+0.57%) ▲|CVX213.28+2.06 (+0.98%) ▲|DE691.75+4.11 (+0.60%) ▲|DHR235.31-0.80 (-0.34%) ▼|DIS119.65+0.44 (+0.37%) ▲|DUK128.77-0.17 (-0.13%) ▼|EMR167.06-0.48 (-0.29%) ▼|FDX322.63+3.15 (+0.99%) ▲|GD367.22-0.22 (-0.06%) ▼|GE342.75+4.84 (+1.43%) ▲|GEV808.24+11.20 (+1.41%) ▲|GILD169.73-1.14 (-0.67%) ▼|GM88.90+0.21 (+0.24%) ▲|GOOG290.63+5.71 (+2.00%) ▲|GOOGL293.45+6.07 (+2.11%) ▲|GS926.81+16.62 (+1.83%) ▲|HD351.31+0.31 (+0.09%) ▲|HON227.64-0.58 (-0.25%) ▼|IBM248.22+3.69 (+1.51%) ▲|INTC62.50+4.37 (+7.52%) ▲|INTU342.64+2.20 (+0.65%) ▲|ISRG449.53-0.51 (-0.11%) ▼|JNJ280.41-0.37 (-0.13%) ▼|JPM343.39+1.32 (+0.39%) ▲|KO97.57+0.66 (+0.68%) ▲|LIN526.55+4.77 (+0.91%) ▲|LLY1,437.29+5.00 (+0.35%) ▲|LMT610.05+6.93 (+1.15%) ▲|LOW231.60-0.27 (-0.12%) ▼|LRCX235.88+13.49 (+6.07%) ▲|MA660.73+1.89 (+0.29%) ▲|MCD274.80-7.37 (-2.61%) ▼|MDLZ66.70+0.16 (+0.24%) ▲|MDT101.61+0.02 (+0.02%) ▲|META628.77-12.62 (-1.97%) ▼|MMM188.88-0.49 (-0.26%) ▼|MO77.39+1.05 (+1.38%) ▲|MRK147.18-0.87 (-0.59%) ▼|MS190.61+3.05 (+1.63%) ▲|MSFT521.13-12.04 (-2.26%) ▼|MU811.30+86.19 (+11.89%) ▲|NEE85.99-0.28 (-0.32%) ▼|NFLX64.54+1.28 (+2.02%) ▲|NKE38.32-0.35 (-0.91%) ▼|NOW102.76+3.15 (+3.16%) ▲|NVDA173.73+4.93 (+2.92%) ▲|ORCL128.38+10.40 (+8.82%) ▲|PEP143.94+0.33 (+0.23%) ▲|PFE29.45+0.09 (+0.31%) ▲|PG167.67-0.99 (-0.59%) ▼|PLTR172.40+3.58 (+2.12%) ▲|PM196.35+2.10 (+1.08%) ▲|QCOM176.57+3.04 (+1.75%) ▲|RTX201.29+1.02 (+0.51%) ▲|SBUX109.89-0.06 (-0.05%) ▼|SCHW92.78-0.25 (-0.27%) ▼|SO93.84+0.19 (+0.20%) ▲|SPG234.75+0.27 (+0.12%) ▲|T22.26+0.32 (+1.46%) ▲|TMO717.71-0.49 (-0.07%) ▼|TMUS172.16+3.08 (+1.82%) ▲|TSLA390.84+11.06 (+2.91%) ▲|TXN309.81+9.29 (+3.09%) ▲|UBER70.68+0.63 (+0.90%) ▲|UNH402.94-2.18 (-0.54%) ▼|UNP302.11+1.49 (+0.50%) ▲|UPS112.45+1.40 (+1.26%) ▲|USB60.70-0.05 (-0.08%) ▼|V425.55+2.55 (+0.60%) ▲|VZ46.60+0.29 (+0.63%) ▲|WFC85.80+0.04 (+0.05%) ▲|WMT125.67+0.12 (+0.10%) ▲|XOM166.71+2.24 (+1.36%) ▲|
15.4 C
New York
Wednesday, November 11, 2026

Tag: development

newsFORsourcecompanycontentinformationreleases1IT

Mindful Therapy Group Expands to Texas to Increase Access to Mental Health Care

AUSTIN, Texas, Aug. 5, 2025 /PRNewswire/ -- Mindful Therapy Group, one of the nation's fastest-growing networks of mental health providers, is expanding into Texas...

Respiree Secures Second FDA 510(k) Clearance, Expands Cardio-Respiratory Wearable to Home Use via 1Bio™ Connected Care Platform

HOUSTON and SINGAPORE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, today announced it has received its second U.S. Food and Drug Administration (FDA) 510(k) clearance. The clearance expands the use of its RS001 cardio-respiratory wearable to home environments and includes approval for its connected care platform marketed as 1Bio™.

New revolutionary brain tech platform ‘ScreenIT’ puts smarter concussion care in reach

SYDNEY, Aug. 6, 2025 /PRNewswire/ -- A revolutionary new brain health assessment platform, ScreenIT, has officially launched, marking a major step forward in how...

Praxis Precision Medicines to Participate in Upcoming Fireside Chat

BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that CEO Marcio Souza will be participating a virtual fireside chat hosted by Piper Sandler senior research analyst Yasmin Rahini on August 7, 2025 at 11:00amEST.

PHX Energy Announces Second Quarter Results and Record Second Quarter Revenue

CALGARY, Alberta, Aug. 05, 2025 (GLOBE NEWSWIRE) --

Second Quarter Highlights

Vitiligo Market to Register Incremental Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight

The vitiligo market is witnessing steady growth due to rising disease awareness, improved diagnostic capabilities, and advancements in treatment options such as JAK inhibitors...

TYK2 Inhibitors Market to Drive Enormous Growth by 2034 Due to Strong Pipeline and Expanding Indications | DelveInsight

The TYK2 inhibitor market is expected to witness substantial growth in the coming years, driven by the increasing prevalence of autoimmune diseases, robust clinical...

LUNDIN GOLD EXPANDS TRANCALOMA MINERALIZATION AND DISCOVERS NEW COPPER-GOLD PORPHYRY SYSTEM AT SANDIA

VANCOUVER, BC, Aug. 5, 2025 /CNW/ - Lundin Gold Inc. (TSX: LUG) (Nasdaq Stockholm: LUG) (OTCQX: LUGDF) ("Lundin Gold" or the "Company") is pleased...

HYSTER-YALE ANNOUNCES SECOND QUARTER 2025 RESULTS

Q2 2025 Consolidated Highlights:  Consolidated revenues improved 5% from Q1 2025 to $957 millionOperating loss of $8.5 million and adjusted operating profit of $7.2 million...

New Research Funding Will Help to Strengthen Canada’s National School Food Program

Applications will be accepted until October 23 OTTAWA, ON, Aug. 5, 2025 /CNW/ - Employment and Social Development Canada (ESDC) and the Canadian Institutes of...

Allison Transmission Powers South America’s First-Ever School Buses Equipped with Automatic Transmissions

Brazil's Fleet Modernization Signals Long-Term Growth Potential in School Bus Market INDIANAPOLIS, Aug. 5, 2025 /PRNewswire/ -- Allison Transmission, a global leader in propulsion technology, is...

BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025

MELVILLE, N.Y., Aug. 05, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced that it will release its second quarter 2025 financial results after market close on Tuesday, August 12, 2025. Following the announcement, BioRestorative management will host a conference call to review the financial results and provide a business update.

Cryoport Reports Second Quarter 2025 Financial Results

Second quarter revenue increased 14% year-over-year to $45.5 millionCommercial Cell & Gene Therapy revenue increased 33% year-over-year to $8.7 millionLife Sciences Services revenue rose...

Kyndryl and Nova Intelligence Announce Strategic Collaboration to Accelerate SAP Transformation for Customers

Kyndryl will align its SAP Services with Nova Intelligence AI agents to speed customer migration to SAP Cloud ERP and deliver cost savings NEW YORK, Aug....

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDevelopment

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers